AMPHETAMINE - ANVISA Registration 10071770822

Access comprehensive regulatory information for AMPHETAMINE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10071770822 and manufactured by ABON BIOPHARM CO. LTD. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including AMERICAN BIO MEDICA CORPORATION, SIEMENS HEALTHCARE DIAGNOSTICS INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10071770822
Registration Details
ANVISA Registration Number: 10071770822
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

AMP One Step Amphetamine Test (Urina)
Risk Class II

Registration Details

10071770822

25351003953201581

50248780000161

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Mar 30, 2015

VIGENTE

09/18/2025 19:00:01